Nippon India Nifty Pharma Etf Datagrid
Category Other ETFs
BMSMONEY Rank 5
Rating
Growth Option
NAV (R) % (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular
Direct
Benchmark
SIP (XIRR) Regular
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.01 0.53 0.94 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.68% -18.91% -15.21% - 11.96%
Fund AUM As on: 30/12/2025 1019 Cr

No data available

NAV Date:

no data

Review Date:

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.68
19.14
0.00 | 68.78 64 | 135 Good
Semi Deviation 11.96
14.24
0.00 | 56.74 57 | 135 Good
Max Drawdown % -15.21
-22.46
-93.23 | 0.00 36 | 135 Good
VaR 1 Y % -18.91
-23.97
-50.15 | 0.00 28 | 135 Very Good
Average Drawdown % 6.41
9.36
0.00 | 48.21 93 | 135 Average
Sharpe Ratio 1.01
-1.19
-119.91 | 1.41 7 | 133 Very Good
Sterling Ratio 0.94
0.45
-0.49 | 1.49 14 | 135 Very Good
Sortino Ratio 0.53
0.19
-1.00 | 0.86 15 | 135 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.68 19.14 0.00 | 68.78 64 | 135 Good
Semi Deviation 11.96 14.24 0.00 | 56.74 57 | 135 Good
Max Drawdown % -15.21 -22.46 -93.23 | 0.00 36 | 135 Good
VaR 1 Y % -18.91 -23.97 -50.15 | 0.00 28 | 135 Very Good
Average Drawdown % 6.41 9.36 0.00 | 48.21 93 | 135 Average
Sharpe Ratio 1.01 -1.19 -119.91 | 1.41 7 | 133 Very Good
Sterling Ratio 0.94 0.45 -0.49 | 1.49 14 | 135 Very Good
Sortino Ratio 0.53 0.19 -1.00 | 0.86 15 | 135 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.